eribulin mesylate
eisai
['eribulin', 'halaven', 'eisai']
eisai presents results of post hoc analysis of eribulin mesylate (halaven) at the european society for medical oncology (esmo) congress 2022 - 
Global Press Releases distribution?? by ACN Newswire